Literature DB >> 20618330

Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection.

Ronen Ben-Ami1, Russell E Lewis, Dimitrios P Kontoyiannis.   

Abstract

Aspergillus fumigatus is an opportunistic filamentous fungus that is currently the most frequent cause of invasive fungal disease in immunosuppressed individuals. Recent advances in our understanding of the pathogenesis of invasive aspergillosis have highlighted the multifactorial nature of A. fumigatus virulence and the complex interplay between host and microbial factors. In this review, we outline current concepts of immune recognition and evasion, angioinvasion and angiogenesis, secondary metabolism and the fungal stress response, and their respective roles in this often lethal infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20618330     DOI: 10.1111/j.1365-2141.2010.08283.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  50 in total

1.  Development of monoclonal antibody-based galactomannoprotein antigen-capture ELISAs to detect Aspergillus fumigatus infection in the invasive aspergillosis rabbit models.

Authors:  Z-Y Wang; J-P Cai; L-W Qiu; W Hao; Y-X Pan; E T K Tung; C C Y Lau; P C Y Woo; S K P Lau; K-Y Yuen; X-Y Che
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-05       Impact factor: 3.267

2.  In vivo veritas: Aspergillus fumigatus proliferation and pathogenesis--conditionally speaking.

Authors:  Robert A Cramer
Journal:  Virulence       Date:  2016       Impact factor: 5.882

3.  Ras-Mediated Signal Transduction and Virulence in Human Pathogenic Fungi.

Authors:  Jarrod R Fortwendel
Journal:  Fungal Genom Biol       Date:  2012

4.  A transcriptional signature accurately identifies Aspergillus Infection across healthy and immunosuppressed states.

Authors:  Julie M Steinbrink; Aimee K Zaas; Marisol Betancourt; Jennifer L Modliszewski; David L Corcoran; Micah T McClain
Journal:  Transl Res       Date:  2020-02-20       Impact factor: 7.012

5.  Exserohilum infections associated with contaminated steroid injections: a clinicopathologic review of 40 cases.

Authors:  Jana M Ritter; Atis Muehlenbachs; Dianna M Blau; Christopher D Paddock; Wun-Ju Shieh; Clifton P Drew; Brigid C Batten; Jeanine H Bartlett; Maureen G Metcalfe; Cau D Pham; Shawn R Lockhart; Mitesh Patel; Lindy Liu; Tara L Jones; Patricia W Greer; Jeltley L Montague; Elizabeth White; Dominique C Rollin; Cynthia Seales; Donna Stewart; Mark V Deming; Mary E Brandt; Sherif R Zaki
Journal:  Am J Pathol       Date:  2013-06-26       Impact factor: 4.307

Review 6.  Immunoevasive Aspergillus virulence factors.

Authors:  Sanjay H Chotirmall; Bojana Mirkovic; Gillian M Lavelle; Noel G McElvaney
Journal:  Mycopathologia       Date:  2014-06-28       Impact factor: 2.574

7.  The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies.

Authors:  Claudia Sassi; Marta Stanzani; Russell E Lewis; Giancarlo Facchini; Alberto Bazzocchi; Michele Cavo; Giuseppe Battista
Journal:  Br J Radiol       Date:  2018-01-10       Impact factor: 3.039

8.  Hypothermic endpoint for an intranasal invasive pulmonary aspergillosis mouse model.

Authors:  Trinka W Adamson; Diana Diaz-Arevalo; Tracey M Gonzalez; Xueli Liu; Markus Kalkum
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

9.  Environmental monitoring for Aspergillus fumigatus in association with an immunosuppressed rabbit model of pulmonary aspergillosis.

Authors:  Kimberly A Such; Vidmantas Petraitis; Ruta Petraitiene; Gittel E Strauss; Patriss-Wais Moradi; Thomas J Walsh
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

10.  Impact of different antimycotics on cytokine levels in an in vitro aspergillosis model in human whole blood.

Authors:  Zoe Oesterreicher; Sabine Eberl; Markus Zeitlinger
Journal:  Infection       Date:  2019-08-01       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.